Broadly neutralizing antibodies and monoclonal V2 antibodies derived from RV305 inhibit capture and replication of HIV-1

被引：0

作者：

Kim, Jiae ^{[1
,2
]}

Villar, Zuzana ^{[1
,2
]}

Jobe, Ousman ^{[1
,2
]}

Rerks-Ngarm, Supachai ^{[3
]}

Pitisuttithum, Punnee ^{[4
]}

Nitayaphan, Sorachai ^{[5
]}

O'Connell, Robert J. ^{[6
]}

Ake, Julie A. ^{[7
]}

Vasan, Sandhya ^{[1
]}

Rao, Venigalla B. ^{[8
]}

Rao, Mangala ^{[2
]}

机构：

[1] US Mil HIV Res Program, Henry M Jackson Fdn Advancement Mil Med, 6720A Rockledge Dr, Bethesda, MD 20817 USA

[2] US Mil HIV Res Program, Walter Reed Army Inst Res, Ctr Infect Dis Res, Lab Adjuvant & Antigen Res, Silver Spring, MD 20910 USA

[3] Minist Publ Hlth, Dept Dis Control, Nonthaburi, Thailand

[4] Mahidol Univ, Fac Trop Med, Vaccine Trial Ctr, Salaya, Thailand

[5] Armed Forces Res Inst Med Sci, Bangkok, Thailand

[6] United States Army Med Component, Armed Forces Res Inst Med Sci, Bangkok, Thailand

[7] US Mil HIV Res Program, Walter Reed Army Inst Res, Ctr Infect Dis Res, Silver Spring, MD 20910 USA

[8] Catholic Univ Amer, Bacteriophage Med Res Ctr, Dept Biol, 620 Michigan Ave,NE, Washington, DC 20064 USA

来源：

VIROLOGY | 2024年 / 597卷

关键词：

Virus capture; Broadly neutralizing antibodies; V2; region; Monoclonal antibodies; Primary virus; HIV-1; vaccine; RV144; RV305; PBMCs; qRT-PCR; EFFICACY; INFECTION; AIDSVAX; REVEAL; BINDS; ALVAC;

D O I：

10.1016/j.virol.2024.110158

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

An important approach to stopping the AIDS epidemic is the development of a vaccine that elicits antibodies that block virus capture, the initial interactions of HIV-1 with the target cells, and replication. We utilized a previously developed qRT-PCR-based assay to examine the effects of broadly neutralizing antibodies (bNAbs), plasma from vaccine trials, and monoclonal antibodies (mAbs) on virus capture and replication. A panel of bNAbs inhibited primary HIV-1 replication in PBMCs but not virus capture. Plasma from RV144 and RV305 trial vaccinees demonstrated inhibition of virus capture with the HIV-1 subtype prevalent in Thailand. Several RV305 derived V2-specific mAbs inhibited virus replication. One of these RV305 derived V2-specific mAbs inhibited both virus capture and replication, demonstrating that it is possible to elicit antibodies by vaccination that inhibit virus capture and replication. Induction of a combination of such antibodies may be the key to protection from HIV-1 acquisition.

引用

页数：8

共 50 条

[41] HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
Jérémy Dufloo
Timothée Bruel
Olivier Schwartz
Retrovirology, 15
[42] Neutralizing the threat: harnessing broadly neutralizing antibodies against HIV-1 for treatment and prevention
Becerra, Juan C.
Hitchcock, Lauren
Vu, Khoa
Gach, Johannes S.
MICROBIAL CELL, 2024, 11 (01): : 207 - 220
[43] Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
Landais, Elise
Moore, Penny L.
RETROVIROLOGY, 2018, 15
[44] Ultrapotent Broadly Neutralizing Human-llama Bispecific Antibodies against HIV-1
Xu, Jianliang
Zhou, Tongqing
McKee, Krisha
Zhang, Baoshan
Liu, Cuiping
Nazzari, Alexandra F.
Pegu, Amarendra
Shen, Chen-Hsiang
Becker, Jordan E.
Bender, Michael F.
Chan, Payton
Changela, Anita
Chaudhary, Ridhi
Chen, Xuejun
Einav, Tal
Kwon, Young Do
Lin, Bob C.
Louder, Mark K.
Merriam, Jonah S.
Morano, Nicholas C.
O'Dell, Sijy
Olia, Adam S.
Rawi, Reda
Roark, Ryan S.
Stephens, Tyler
Teng, I-Ting
Tourtellott-Fogt, Emily
Wang, Shuishu
Yang, Eun Sung
Shapiro, Lawrence
Tsybovsky, Yaroslav
Doria-Rose, Nicole A.
Casellas, Rafael
Kwong, Peter D.
ADVANCED SCIENCE, 2024, 11 (26)
[45] Removal of variable domain N-linked glycosylation as a means to improve the homogeneity of HIV-1 broadly neutralizing antibodies
Chuang, Gwo-Yu
Asokan, Mangaiarkarasi
Ivleva, Vera B.
Pegu, Amarendra
Yang, Eun Sung
Zhang, Baoshan
Chaudhuri, Rajoshi
Geng, Hui
Lin, Bob C.
Louder, Mark K.
McKee, Krisha
O'Dell, Sijy
Wang, Hairong
Zhou, Tongqing
Doria-Rose, Nicole A.
Kueltzo, Lisa A.
Lei, Q. Paula
Mascola, John R.
Kwong, Peter D.
MABS, 2020, 12 (01)
[46] Neutralizing Monoclonal Antibodies to Fight HIV-1: On the Threshold of Success
Pablo Jaworski, Juan
Vendrell, Alejandrina
Matias Chiavenna, Sebastian
FRONTIERS IN IMMUNOLOGY, 2017, 7
[47] Molecular Evolution of Broadly Neutralizing Llama Antibodies to the CD4-Binding Site of HIV-1
McCoy, Laura E.
Rutten, Lucy
Frampton, Dan
Anderson, Ian
Granger, Luke
Bashford-Rogers, Rachael
Dekkers, Gillian
Strokappe, Nika M.
Seaman, Michael S.
Koh, Willie
Grippo, Vanina
Kliche, Alexander
Verrips, Theo
Kellam, Paul
Fassati, Ariberto
Weiss, Robin A.
PLOS PATHOGENS, 2014, 10 (12)
[48] Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice
Dosenovic, Pia
von Boehmer, Lotta
Escolano, Amelia
Jardine, Joseph
Freund, Natalia T.
Gitlin, Alexander D.
McGuire, Andrew T.
Kulp, Daniel W.
Oliveira, Thiago
Scharf, Louise
Pietzsch, John
Gray, Matthew D.
Cupo, Albert
van Gils, Marit J.
Yao, Kai-Hui
Liu, Cassie
Gazumyan, Anna
Seaman, Michael S.
Bjoerkman, Pamela J.
Sanders, Rogier W.
Moore, John P.
Stamatatos, Leonidas
Schief, William R.
Nussenzweig, Michel C.
CELL, 2015, 161 (07) : 1505 - 1515
[49] Design of an optimal combination therapy with broadly neutralizing antibodies to suppress HIV-1
LaMont, Colin
Otwinowski, Jakub
Vanshylla, Kanika
Gruell, Henning
Klein, Florian
Nourmohammad, Armita
ELIFE, 2022, 11
[50] Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo
Lu, Ching-Lan
Murakowski, Dariusz K.
Bournazos, Stylianos
Schoofs, Till
Sarkar, Debolina
Halper-Stromberg, Ariel
Horwitz, Joshua A.
Nogueira, Lilian
Golijanin, Jovana
Gazumyan, Anna
Ravetch, Jeffrey V.
Caskey, Marina
Chakraborty, Arup K.
Nussenzweig, Michel C.
SCIENCE, 2016, 352 (6288) : 1001 - 1004

← 1 2 3 4 5 →